MOLECULAR-BASIS FOR RATIONAL MEGAPRESCRIBING IN ULTRARAPID HYDROXYLATORS OF DEBRISOQUINE

被引:202
作者
BERTILSSON, L
DAHL, ML
SJOQVIST, F
ABERGWISTEDT, A
HUMBLE, M
JOHANSSON, I
LUNDQVIST, E
INGELMANSUNDBERG, M
机构
[1] KAROLINSKA INST,ST GORANS CHILDRENS HOSP,DEPT PSYCHIAT,S-11281 STOCKHOLM,SWEDEN
[2] KAROLINSKA INST,DANDERYDS HOSP,DEPT PSYCHIAT,S-10401 STOCKHOLM 60,SWEDEN
[3] KAROLINSKA INST,DEPT PHYSIOL CHEM,S-10401 STOCKHOLM 60,SWEDEN
关键词
D O I
10.1016/0140-6736(93)92546-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:63 / 63
页数:1
相关论文
共 9 条
[1]   CLINICAL PHARMACOKINETICS OF CLOMIPRAMINE [J].
BALANTGORGIA, AE ;
GEXFABRY, M ;
BALANT, LP .
CLINICAL PHARMACOKINETICS, 1991, 20 (06) :447-462
[2]   EXTREMELY RAPID HYDROXYLATION OF DEBRISOQUINE - A CASE-REPORT WITH IMPLICATION FOR TREATMENT WITH NORTRIPTYLINE AND OTHER TRICYCLIC ANTIDEPRESSANTS [J].
BERTILSSON, L ;
ABERGWISTEDT, A ;
GUSTAFSSON, LL ;
NORDIN, C .
THERAPEUTIC DRUG MONITORING, 1985, 7 (04) :478-480
[3]   PRONOUNCED DIFFERENCES BETWEEN NATIVE CHINESE AND SWEDISH POPULATIONS IN THE POLYMORPHIC HYDROXYLATIONS OF DEBRISOQUIN AND S-MEPHENYTOIN [J].
BERTILSSON, L ;
LOU, YQ ;
DU, YL ;
LIU, Y ;
KUANG, TY ;
LIAO, XM ;
WANG, KY ;
REVIRIEGO, J ;
ISELIUS, L ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (04) :388-397
[4]   CLINICAL-SIGNIFICANCE OF THE SPARTEINE-DEBRISOQUINE OXIDATION POLYMORPHISM [J].
BROSEN, K ;
GRAM, LF .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (06) :537-547
[5]   ANALYSIS OF THE CYP2D6 GENE IN RELATION TO DEBRISOQUIN AND DESIPRAMINE HYDROXYLATION IN A SWEDISH POPULATION [J].
DAHL, ML ;
JOHANSSON, I ;
PALMERTZ, MP ;
INGELMANSUNDBERG, M ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (01) :12-17
[6]  
DAHL ML, IN PRESS PHARMACOGEN
[7]   GENOTYPING OF POOR METABOLIZERS OF DEBRISOQUINE BY ALLELE-SPECIFIC PCR AMPLIFICATION [J].
HEIM, M ;
MEYER, UA .
LANCET, 1990, 336 (8714) :529-532
[8]   EVOLUTION OF A HIGHLY POLYMORPHIC HUMAN CYTOCHROME P450 GENE-CLUSTER - CYP2D6 [J].
HEIM, MH ;
MEYER, UA .
GENOMICS, 1992, 14 (01) :49-58
[9]  
TRASKMAN L, 1979, CLIN PHARMACOL THER, V26, P600